In This Article:
Oxford Nanopore Technologies (LON:ONT) First Half 2023 Results
Key Financial Results
-
Revenue: UK£86.0m (down 30% from 1H 2022).
-
Net loss: UK£70.1m (loss widened by 132% from 1H 2022).
-
UK£0.085 loss per share (further deteriorated from UK£0.037 loss in 1H 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Oxford Nanopore Technologies Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 14%.
Looking ahead, revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Life Sciences industry in the United Kingdom.
Performance of the British Life Sciences industry.
The company's shares are down 8.2% from a week ago.
Risk Analysis
Be aware that Oxford Nanopore Technologies is showing 1 warning sign in our investment analysis that you should know about...
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.